Candriam SCA’s ICU Medical ICUI Stock Holding History

Candriam SCA’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,500	Closed	-$424K	–	830
2018 Q3	$424K	Hold	1,500	–	–	0.01%	729
2018 Q2	$440K	Buy	+1,500	New	+$410K	0.01%	711

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Candriam SCA's ICUI Position: Q4 2018 in Review

Candriam SCA sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 1,500 shares — an estimated $424K sold.

Candriam SCA first reported a position in ICUI in Q2 2018 and held it in 2 quarters. The position peaked at $440K in Q2 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

Candriam SCA reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
Candriam SCA sold 1,500 ICU Medical shares in Q4 2018, an estimated $424K.
Candriam SCA first reported a position in ICU Medical in Q2 2018 and held it in 2 quarters.
Candriam SCA's ICU Medical position peaked at $440K in Q2 2018.
294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.